PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 123 filers reported holding PROVENTION BIO INC in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,247,000 | -9.8% | 499,271 | -19.8% | 0.99% | +10.4% |
| Q2 2022 | $2,490,000 | -34.9% | 622,568 | +19.1% | 0.90% | +16.8% |
| Q1 2022 | $3,825,000 | +9.8% | 522,568 | -15.7% | 0.77% | +33.9% |
| Q4 2021 | $3,483,000 | 0.0% | 619,707 | +13.9% | 0.57% | -19.1% |
| Q3 2021 | $3,483,000 | -76.8% | 544,222 | -38.6% | 0.71% | -77.7% |
| Q4 2020 | $15,020,000 | +180.7% | 886,662 | +112.6% | 3.18% | -1.3% |
| Q3 2020 | $5,351,000 | +32.1% | 417,092 | +45.2% | 3.22% | -3.1% |
| Q2 2020 | $4,052,000 | – | 287,172 | – | 3.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
| Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
| 683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
| Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
| GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
| Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
| Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
| Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |